Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
Winnie Yeo(Chinese University of Hong Kong), Benny Zee(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), Philip J. Johnson(Prince of Wales Hospital), Stephen L. Chan(Chinese University of Hong Kong), Tony Mok(Chinese University of Hong Kong), Pui Wah Hui(Queen Mary Hospital), J. J. Lee, Anthony T.�C. Chan(Chinese University of Hong Kong), To‐Wai Leung(Chinese University of Hong Kong), Frankie Mo(Chinese University of Hong Kong), Alan Tang(Chinese University of Hong Kong), Jane Koh(Chinese University of Hong Kong)
Cited by 121
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k